Andere Kunden interessierten sich auch für
![Population Pharmacokinetics of Phenytoin in Epileptic Patients]( "Population Pharmacokinetics of Phenytoin in Epileptic Patients")
Population Pharmacokinetics of Phenytoin in Epileptic Patients32,99 €![Docking Approach And Study Of Some Docking Parameters With MOE]( "Docking Approach And Study Of Some Docking Parameters With MOE")
Docking Approach And Study Of Some Docking Parameters With MOE26,99 €![Repurposing Drugs to Find HIV-1 Protease Inhibitors: A Virtual Study]( "Repurposing Drugs to Find HIV-1 Protease Inhibitors: A Virtual Study")
Repurposing Drugs to Find HIV-1 Protease Inhibitors: A Virtual Study23,99 €![Molecular modeling & pharmacological studies on ER modulators]( "Molecular modeling & pharmacological studies on ER modulators")
Molecular modeling & pharmacological studies on ER modulators51,99 €![Molecular Docking Studies to Improve Bioavaliability of P-gp Substrate]( "Molecular Docking Studies to Improve Bioavaliability of P-gp Substrate")
Molecular Docking Studies to Improve Bioavaliability of P-gp Substrate29,99 €![Anticancer Tyrosine Kinase Inhibitors - QSAR And Molecular Modeling]( "Anticancer Tyrosine Kinase Inhibitors - QSAR And Molecular Modeling")
Anticancer Tyrosine Kinase Inhibitors - QSAR And Molecular Modeling32,99 €![QSAR and docking studies of urea derivatives as antitubercular agents]( "QSAR and docking studies of urea derivatives as antitubercular agents")
QSAR and docking studies of urea derivatives as antitubercular agents23,99 €
Neurokinin-1 (NK-1) receptor regulates many biological functions related to cancer, such as tumor cell proliferation, angiogenesis and migration of tumor cells for invasion and metastasis. The NK-1 receptor antagonists specifically inhibit tumor cell proliferation, migration of the tumor cells and show antiangiogenic effect. Therefore, the development of NK-1 antagonists for the treatment of cancer is of current interest. The 3D structure of NK-1 is not available from protein data bank. This hampers the design of selective NK-1 antagonists. This book describes the homology modeling of the human NK-1 receptor using multiple templates to provide structural basis for the design of new NK-1 inhibitors and anticancer agents. The authors anticipate that the book will be very useful for the researchers who are working on the design and development of NK-1 receptor antagonists and anticancer agents.